Bibliometrics and visual analysis of the research status and trends of placenta accreta spectrum disorder over the past decade.

Objective: This study aims to perform a bibliometric analysis of the literature concerning placenta accreta spectrum disorders (PASDs) over the past decade, with the objective of elucidating the current status and developmental trends in global research. It seeks to systematically assess the associated risk factors, diagnostic methodologies and therapies of PASDs, thereby providing a foundation for enhancing diagnostic and management strategies.

Methods: The Web of Science database was utilized to retrieve literature pertaining to PASDs from 2015 to 2024. Employing data visualization tools such as Citespace, VOSviewer, and Bibliometric, this study analyzes various metrics including the number of publications, citation trends, contributions by countries and institutions, author influence, and journal distribution.

Results: A total of 1860 English-language articles were included in the analysis. Over the past decade, the number of publications reached a peak of 271 in 2021, and the citation rate also increased steadily. The United States and China have emerged as the principal contributors to research in this area, with Baylor College of Medicine demonstrating the highest research output. According to the analysis of author contribution, Fox KA is the leading author in the number of publications, and Jauniaux E is the most cited author. The top journals include "Journal of Maternal-Fetal & Neonatal Medicine" and "American Journal of Obstetrics and Gynecology". In addition, keyword analysis revealed the evolution and development of topics related to placenta implantation, such as "diagnosis", "complications", "management", etc.

Conclusion: This study highlights the need for early identification and multidisciplinary collaboration in PASDs management. Maternal and infant outcomes will improve with advances in early diagnostic techniques, optimized management strategies, and exploration of new treatments. In the future, maintaining a focus on the latest researches and guideline updates in this field is crucial.